Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Autor: Sands, Bruce E., Peyrin-Biroulet, Laurent, Kierkus, Jaroslaw, Higgins, Peter D.R., Fischer, Monika, Jairath, Vipul, Hirai, Fumihito, D’Haens, Geert, Belin, Ruth M., Miller, Debra, Gomez-Valderas, Elisa, Naegeli, April N., Tuttle, Jay L., Pollack, Paul F., Sandborn, William J.
Zdroj: In Gastroenterology February 2022 162(2):495-508
Databáze: ScienceDirect